Back to Selection     Print       Date : 30 Sep 2026
Fund Summary
Quantum Nifty 50 ETF
[Equity: Index]  
 
Fund Details
Fund Type Growth Launch Date 10-Jul-08
Corpus(Cr.) 60.00 Latest NAV 252.8268 As on 29-10-2026
Equity(%) 99.99 52 Week High 287.603
Debt(%) 0.01 52 Week Low 244.18
Others(%) 0.00 Exit Load 0
Minimum Investment - Availability INF082J01028
Entry Load Nil Expense Ratio(%) 0.00
Scheme Benchmark NIFTY 50 TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Hitendra Parekh
 
Riskometer
Investors understand that their principal will be at Moderately High risk
 
Scheme Objective
The scheme seeks to generate returns that are commensurate with the performance of the NIFTY 50 Index, subject to tracking errors. There is no assurance that the investment objective of the Scheme will be achieved.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 100.00%
Top 10 Holdings 100.00%
Top 25 Holdings 100.00%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Equity MF 99.99
Cash 0.01
 
 
 
 
 
Portfolio Metrics
PB Ratio 2.72
PE Ratio 18.24
 
Top 25 Holdings
Holdings Net Asset(%)
Quantum Nifty 50 ETF 99.99
TREPS 0.16
Net Receivable/(payable) -0.15

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
1.01% -5.25% -4.38% -11.09%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
1.01% -5.23% -4.33% -11.05%
 
Scheme Benchmark [NSE - Nifty 50 TRI]
1.01% -5.23% -4.33% -11.05%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
-2.16% 7.48% 6.48% 10.57%
 
 
-2.07% 7.60% 6.59% 11.58%
 
 
-2.07% 7.60% 6.59% 11.58%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
Quantum Nifty 50 ETF 14.13% -0.1117 13.0866% 47.3613 0.0259
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
Quantum Nifty 50 ETF -1.5391% 1.0017 -0.0191 5.3293 -0.3039
 
Back to Selection